John R. Jaskowiak

Mr. Jaskowiak is Chief Operating Officer at Angiocrine Bioscience responsible for overseeing the administration and operation of the business, as well as, leading the implementation of company strategies as it transitions into a clinical-stage company. Previously he held the title of Vice President, Corporate Development, assisting in numerous corporate financing and operational development activities to advance the company’s E-CEL™ platform. John comes to Angiocrine Bioscience with over 25 years of commercial experience within the Life Sciences and Diagnostics industries. Prior to joining Angiocrine Bioscience, he was Vice President of Marketing and Sales at SDIX, where he led the transformation of the commercial team into a focused life science organization, developing Go-To-Market strategies and supporting business plans for its core business and new business growth initiatives for its two complementary technologies for the generation and isolation of novel monoclonal antibodies. He has also held various management roles at Hewlett-Packard, Agilent Technologies, Affymetrix, ExonHit Therapeutics, and Meso Scale Diagnostics. John has a degree in Biology from Temple University, Philadelphia, PA.